KEYONIA JOHNSON: Open Payments
NPI 1891123659 · SALUDA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 32 payments from 14 companies in 2025. Trend: 2023 $980 · 2024 $582 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Abbott Laboratories | 3 | $72 |
| Novo Nordisk Inc | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Corcept Therapeutics | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $30 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, REXULTI, VRAYLAR, Kerendia, Ozempic, GVOKE HYPOPEN, Korlym.
Industry payments across SC — which companies pay providers there.
